Article ID Journal Published Year Pages File Type
2081947 Drug Discovery Today: Disease Mechanisms 2007 8 Pages PDF
Abstract

Renal fibrosis is the hallmark of chronic kidney disease (CKD) leading to organ failure and the need for renal replacement therapy. An increasing body of evidence suggests that tissue hypoxia, which is sustained, among other things, by progressive microvascular loss, plays an important role in the pathogenesis of ongoing renal fibrosis via direct and indirect mechanisms. Therapeutic strategies that target chronic hypoxia may be of benefit in ameliorating this intractable disease.

Section editor:Michael S. Goligorsky – Renal Research Institute, New York Medical College, Valhalla, NY, USA

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biotechnology
Authors
, ,